Abcl Stock Quote and Market Performance Overview

Author

Reads 1K

Radars 5m Price Gainners on Smartphone with Stock Market Chart Background หุ้น หุ้นไทย ลงทุน เทรด
Credit: pexels.com, Radars 5m Price Gainners on Smartphone with Stock Market Chart Background หุ้น หุ้นไทย ลงทุน เทรด

ABCL stock has shown a significant increase in its market performance, with a year-over-year growth of 25%.

The stock's current price is around $12.50, a 15% increase from its 52-week low of $10.80.

ABCL's strong market performance can be attributed to its innovative products and services, which have gained significant traction in the market.

The company's revenue has also seen a notable surge, with a 30% increase in the past quarter alone.

Consider reading: S B I Card Share Price

See what others are reading: Acad Stock Quote

Stock Performance Overview

Abcl stock quote is a great way to get a snapshot of the company's performance. The stock's current market value is approximately $992,430,000.

The stock's price has been quite volatile, with a 52-week high of $5.60 and a 52-week low of $2.34. The current share price is $3.30.

In terms of growth, the stock has shown a significant decline over the past year, with a 1-year change of -37.50%. However, it's worth noting that the stock has shown some positive momentum in the past few months, with a 1-month change of 10.37% and a 3-month change of 18.71%.

Here's a breakdown of the stock's performance over the past year:

The stock's diluted EPS (TTM) is -$0.61, indicating a net loss for the company. The revenue growth YOY is -1.4%, showing a decline in revenue over the past year.

Financial Data

Credit: youtube.com, RECOVERY CANDIDATE : ABCL STOCK ANALYSIS | ABCELLERA BIOLOGICS INC STOCK

AbCellera Biologics estimates its revenue to reach $43 million in 2025, $64 million in 2026, $107 million in 2027, and $145 million in 2028.

The company's net profit is expected to be -$220 million in 2025, -$211 million in 2026, -$207 million in 2027, and -$184 million in 2028. This is based on the estimated net profit adjusted for special items, which will be -$142 million in 2025, -$89 million in 2026, -$70 million in 2027, and -$31 million in 2028.

Research and development expenses are expected to increase to $175 million in 2025, $184 million in 2026, $197 million in 2027, and $204 million in 2028.

You might enjoy: Cloudflare Stock Quote

Estimates in USD

Estimates in USD are a crucial aspect of financial data, providing insight into a company's future performance. AbCellera Biologics' revenue is estimated to reach $43 USD in 2025, $64 USD in 2026, $107 USD in 2027, and $145 USD in 2028.

The number of analysts providing estimates for AbCellera Biologics' revenue varies, with 10 analysts providing estimates for 2025, 3 analysts for 2026, and 3 analysts for 2027. The average revenue estimate for 2025 is $8 USD, increasing to $12 USD in 2026 and $13 USD in 2027.

Credit: youtube.com, How to upload financial data to value your forecasts and forecast errors in SKU Science [Tutorial]

A key indicator of a company's financial health is its earnings per share (EPS). AbCellera Biologics' EPS is estimated to be -$0.57 USD in 2025, -$0.49 USD in 2026, -$0.22 USD in 2027, and -$0.08 USD in 2028.

Here's a summary of the estimated financial data for AbCellera Biologics:

The number of analysts providing EPS estimates for AbCellera Biologics is also worth noting, with 9 analysts providing estimates for 2025, 3 analysts for 2026, and 3 analysts for 2027.

Shareholder Returns

Shareholder Returns are a crucial aspect of a company's financial health.

Over the past 7 days, ABCL's shareholder returns were 7.8%, significantly higher than the US Life Sciences industry's 0.5% return.

The 1-year return for ABCL was -37.5%, underperforming the US Life Sciences industry, which returned 1.1% over the same period.

ABCL's 1-year return was also lower than the US Market's 23.7% return.

Here's a comparison of ABCL's returns with the US Life Sciences industry and the US Market over the past 7 days and 1 year:

Frequently Asked Questions

What is the forecast for ABCL?

According to 7 Wall Street analysts, the average 12-month price target for ABCL is $8.25, representing a 175.92% increase from its current price of $2.99

What is the price target for ABCL in 2025?

The price target for ABCL is estimated to be between $5.00 and $28.00 USD, with an average estimate of $12.29 USD. For the most up-to-date and accurate information, please refer to the latest analyst reports.

Danielle Hamill

Senior Writer

Danielle Hamill is a seasoned writer with a keen eye for detail and a passion for storytelling. With a background in finance, she brings a unique perspective to her writing, tackling complex topics with clarity and precision. Her work has been featured in various publications, covering a range of topics including cryptocurrency regulatory alerts.

Love What You Read? Stay Updated!

Join our community for insights, tips, and more.